Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
E

EHC

NYSE

Encompass Health Corp

Latest disclosureSeptember 1, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 9 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 44

Limited filing history
All44Buying0Selling9Other35
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

9 of 44 trades · April 15, 2026 – August 31, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 9 trades on this page.

Sale disclosed

Andrew L. Price

Chief Accounting Officer

Encompass Health Common Stock

Reported value
$630.17K
Reported price
$120.93 / share
Traded August 31, 2026Filed September 1, 2026SEC filing
Sale disclosed

John Patrick Darby

EVP, Gen Counsel & Secretary

Encompass Health Common Stock

Reported value
$588.26K
Reported price
$121.09 / share
Traded August 31, 2026Filed September 1, 2026SEC filing
Sale disclosed

Douglas E. Coltharp

EVP & Chief Financial Officer

Encompass Health Common Stock

Reported value
$2.37M
Reported price
$125.38 / share
Traded August 10, 2026Filed August 11, 2026SEC filing
Sale disclosed

Mark J. Tarr

President & CEO

Encompass Health Common Stock

Reported value
$21.53M
Reported price
$125.46 / share
Traded August 10, 2026Filed August 11, 2026SEC filing
Sale disclosed

Mark J. Tarr

President & CEO

Encompass Health Common Stock

Reported value
$199.05K
Reported price
$126.06 / share
Traded August 10, 2026Filed August 11, 2026SEC filing
Sale disclosed

John Patrick Darby

EVP, Gen Counsel & Secretary

Encompass Health Common Stock

Reported value
$1.12M
Reported price
$125.95 / share
Traded August 10, 2026Filed August 11, 2026SEC filing
Sale disclosed

Douglas E. Coltharp

EVP & Chief Financial Officer

Encompass Health Common Stock

Reported value
$2.96M
Reported price
$106.83 / share
Traded May 15, 2026Filed May 18, 2026SEC filing
Sale disclosed

Douglas E. Coltharp

EVP & Chief Financial Officer

Encompass Health Common Stock

Reported value
$107.28
Reported price
$107.28 / share
Traded May 15, 2026Filed May 18, 2026SEC filing
Sale disclosed

Patrick William Tuer

EVP, Chief Operating Officer

Encompass Health Common Stock

Reported value
$71.31K
Reported price
$104.56 / share
Traded May 11, 2026Filed May 12, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Accounting OfficerEncompass Health Common StockSale5,211$120.93 / share$630.17KAug 31Filed Sep 1 · 1d laterSEC filing
EVP, Gen Counsel & SecretaryEncompass Health Common StockSale4,858$121.09 / share$588.26KAug 31Filed Sep 1 · 1d laterSEC filing
EVP & Chief Financial OfficerEncompass Health Common StockSale18,869$125.38 / share$2.37MAug 10Filed Aug 11 · 1d laterSEC filing
President & CEOEncompass Health Common StockSale2 trades173,148avg $125.47 / share$21.72MAug 10Filed Aug 11 · 1d later
2 filings
  • 171,569 @ $125.46 · $21.53MSEC filing
  • 1,579 @ $126.06 · $199.05KSEC filing
EVP, Gen Counsel & SecretaryEncompass Health Common StockSale8,906$125.95 / share$1.12MAug 10Filed Aug 11 · 1d laterSEC filing
EVP & Chief Financial OfficerEncompass Health Common StockSale2 trades27,694avg $106.83 / share$2.96MMay 15Filed May 18 · 3d later
2 filings
  • 27,693 @ $106.83 · $2.96MSEC filing
  • 1 @ $107.28 · $107.28SEC filing
EVP, Chief Operating OfficerEncompass Health Common StockSale682$104.56 / share$71.31KMay 11Filed May 12 · 1d laterSEC filing

Congress transactions 3

All Congress filings
Sale disclosed

Encompass Health Corporation Common Stock (EHC) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 31, 2025
Filed November 21, 2025 · 21d laterOriginal report
Sale disclosed

Encompass Health Corporation Common Stock (EHC) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 30, 2025
Filed November 21, 2025 · 22d laterOriginal report
Purchase disclosed

Encompass Health Corporation Common Stock (EHC) · Stock

The filing reports a purchase for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 30, 2025
Filed November 21, 2025 · 22d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000785161
Latest public acceptance
Sep 1, 2026, 04:21 PM UTC
Score calculated
Oct 8, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.